# Shire Human Genetic Therapies, Inc., North Reading, MA – FDA Inspections

Source: https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/1d1f96ea-a020-4019-96a3-aee02e95246e

> Inspection records and compliance data for Shire Human Genetic Therapies, Inc. in North Reading, Massachusetts. 4 FDA inspections on record, last inspected January 05, 2017.

---

## Details

- Name: Shire Human Genetic Therapies, Inc.
- FEI Number: 3008424653
- Address Line 1: 200 Riverpark Dr
- City: North Reading
- State: Massachusetts
- Zip Code: 01864
- Country Name: United States
- Address: 200 Riverpark Dr, North Reading, Massachusetts 01864, United States
- Country: United States

## Related Documents

- FDA Inspection 1002403 - Shire Human Genetic Therapies, Inc. - 2017-01-05 — classification: No Action Indicated (NAI), source: FDA, date: January 5, 2017
- [FDA Inspection 872432 - Shire Human Genetic Therapies, Inc. - 2014-01-30](https://www.keypedia.com/records/fda_inspections/shire-human-genetic-therapies-inc/a955aec1-b47e-4cf8-934f-c6c8600f2e01) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 30, 2014
- FDA Inspection 762708 - Shire Human Genetic Therapies, Inc. - 2012-01-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 6, 2012
- FDA Inspection 716751 - Shire Human Genetic Therapies, Inc. - 2011-02-16 — classification: No Action Indicated (NAI), source: FDA, date: February 16, 2011

## Related Companies

- [Nivagen Pharmaceuticals Inc](https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/3eba9a8d-d560-49ef-956e-aa59eea20360)
- [Biospectra, Inc.](https://www.keypedia.com/companies/biospectra-inc/bb32a74e-c76f-4ea1-b504-bf2a62f1795d)
- [Incog Biopharma Services, Inc.](https://www.keypedia.com/companies/incog-biopharma-services-inc/6e8ec293-9414-4eec-921f-5e0ca40b7b20)
- [3M Company](https://www.keypedia.com/companies/3m-company/2cb29977-0876-46cd-88ee-7c37ec8ca321)
- [Avista Pharma Solutions, Inc. dba Cambrex](https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824)
- [Liquidia Technologies, Inc.](https://www.keypedia.com/companies/liquidia-technologies-inc/4c70764b-1078-4221-a9a3-804b2e1be087)
- [Bioindustria Laboratorio Italiano Medicinali S.p.A](https://www.keypedia.com/companies/bioindustria-laboratorio-italiano-medicinali-spa/29213adb-f4cb-488a-b5f3-0ae54d911fe8)
- [Boehringer Ingelheim Hellas A.E.](https://www.keypedia.com/companies/boehringer-ingelheim-hellas-ae/3d05b843-ddcd-47d7-8b0c-de7d170d3197)
- [Avon Cosmetics Manufacturing, S. de R.L. de C.V.](https://www.keypedia.com/companies/avon-cosmetics-manufacturing-s-de-rl-de-cv/0b454282-8607-4500-9fe4-a5c4f42a880c)
- [BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)](https://www.keypedia.com/companies/brightgene-pharmaceutical-co-ltdjiangyun-road/fee25d1b-c470-4be1-8b02-9ffa6e044007)